216 related articles for article (PubMed ID: 35119135)
1. Therapeutic plasma exchange for the treatment of refractory necrotizing autoimmune myopathy.
Kruse RL; Albayda J; Vozniak SO; Lawrence CE; Goel R; Lokhandwala PM; Ness PM; Tobian AAR; Bloch EM; Crowe EP
J Clin Apher; 2022 Jun; 37(3):253-262. PubMed ID: 35119135
[TBL] [Abstract][Full Text] [Related]
2. Exploring necrotizing autoimmune myopathies with a novel immunoassay for anti-3-hydroxy-3-methyl-glutaryl-CoA reductase autoantibodies.
Drouot L; Allenbach Y; Jouen F; Charuel JL; Martinet J; Meyer A; Hinschberger O; Bader-Meunier B; Kone-Paut I; Campana-Salort E; Eymard B; Tournadre A; Musset L; Sibilia J; Marie I; Benveniste O; Boyer O;
Arthritis Res Ther; 2014 Feb; 16(1):R39. PubMed ID: 24484965
[TBL] [Abstract][Full Text] [Related]
3. Clinical Features and Treatment Outcomes of Necrotizing Autoimmune Myopathy.
Kassardjian CD; Lennon VA; Alfugham NB; Mahler M; Milone M
JAMA Neurol; 2015 Sep; 72(9):996-1003. PubMed ID: 26192196
[TBL] [Abstract][Full Text] [Related]
4. Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy.
Watanabe Y; Uruha A; Suzuki S; Nakahara J; Hamanaka K; Takayama K; Suzuki N; Nishino I
J Neurol Neurosurg Psychiatry; 2016 Oct; 87(10):1038-44. PubMed ID: 27147697
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy reversed myopathy but not cardiomyopathy in a necrotizing autoimmune myopathy patient with positive anti-SRP and MDA-5 autoantibodies.
Ma X; Xu L; Li Y; Bu B
BMC Cardiovasc Disord; 2021 Feb; 21(1):88. PubMed ID: 33579193
[TBL] [Abstract][Full Text] [Related]
6. Proposed cut-off for reactivity of anti-HMGCR and anti-SRP antibodies in patients statin-exposed and statin-unexposed.
Carvalho AAS; Silva VGD; Vieira TF; Delgado PO; Corazini R; Feder D; Fonseca FLA
Medicine (Baltimore); 2018 Aug; 97(35):e11858. PubMed ID: 30170376
[TBL] [Abstract][Full Text] [Related]
7. Treatment and outcomes in necrotising autoimmune myopathy: An Australian perspective.
Ashton C; Junckerstorff R; Bundell C; Hollingsworth P; Needham M
Neuromuscul Disord; 2016 Nov; 26(11):734-740. PubMed ID: 27665513
[TBL] [Abstract][Full Text] [Related]
8. Statin-naïve anti-HMGCR antibody-mediated necrotizing myopathy in China.
Jiao Y; Cai S; Lin J; Zhu W; Xi J; Li J; Yue D; Zhang T; Qiao K; Wang Y; Zhao C; Lu J
J Clin Neurosci; 2018 Nov; 57():13-19. PubMed ID: 30205933
[TBL] [Abstract][Full Text] [Related]
9. Anti-signal Recognition Particle Necrotizing Autoimmune Myopathy: An Atypical Presentation.
Khan MH; Patel A; Pendharkar S
Cureus; 2018 Dec; 10(12):e3766. PubMed ID: 30820385
[TBL] [Abstract][Full Text] [Related]
10. [Dermatomyositis-like syndrome revealing statin-induced necrotizing autoimmune myopathy with anti-HMGCR antibodies].
Merlant M; Fite C; Kottler D; Maisonobe L; Dossier A; Deschamps L; Descamps V
Ann Dermatol Venereol; 2019 Sep; 146(8-9):550-556. PubMed ID: 30929872
[TBL] [Abstract][Full Text] [Related]
11. Myositis-specific autoantibodies, a cornerstone in immune-mediated necrotizing myopathy.
Anquetil C; Boyer O; Wesner N; Benveniste O; Allenbach Y
Autoimmun Rev; 2019 Mar; 18(3):223-230. PubMed ID: 30639649
[TBL] [Abstract][Full Text] [Related]
12. Immune-mediated necrotizing myopathy (IMNM): A myopathological challenge.
Merlonghi G; Antonini G; Garibaldi M
Autoimmun Rev; 2022 Feb; 21(2):102993. PubMed ID: 34798316
[TBL] [Abstract][Full Text] [Related]
13. [Retrospective study on clinical manifestation, thigh MRI and electrophysiology characteristics of immune-mediated necrotizing myopathy].
Qiao LY; Shi Q; Lin MY; Liu J; Chen ZJ; Pu C
Zhonghua Nei Ke Za Zhi; 2022 Oct; 61(10):1144-1151. PubMed ID: 36207969
[No Abstract] [Full Text] [Related]
14. Immune-mediated myopathy related to anti 3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies as an emerging cause of necrotizing myopathy induced by statins.
Lahaye C; Beaufrére AM; Boyer O; Drouot L; Soubrier M; Tournadre A
Joint Bone Spine; 2014 Jan; 81(1):79-82. PubMed ID: 23953224
[TBL] [Abstract][Full Text] [Related]
15. Clinical spectrums and outcomes of necrotizing autoimmune myopathy versus other idiopathic inflammatory myopathies: a multicenter case-control study.
Yongchairat K; Tanboon J; Waisayarat J; Narongroeknawin P; Chevaisrakul P; Dejthevaporn C; Katchamart W
Clin Rheumatol; 2019 Dec; 38(12):3459-3469. PubMed ID: 31446540
[TBL] [Abstract][Full Text] [Related]
16. Anti-HMGCR autoantibodies in European patients with autoimmune necrotizing myopathies: inconstant exposure to statin.
Allenbach Y; Drouot L; Rigolet A; Charuel JL; Jouen F; Romero NB; Maisonobe T; Dubourg O; Behin A; Laforet P; Stojkovic T; Eymard B; Costedoat-Chalumeau N; Campana-Salort E; Tournadre A; Musset L; Bader-Meunier B; Kone-Paut I; Sibilia J; Servais L; Fain O; Larroche C; Diot E; Terrier B; De Paz R; Dossier A; Menard D; Morati C; Roux M; Ferrer X; Martinet J; Besnard S; Bellance R; Cacoub P; Arnaud L; Grosbois B; Herson S; Boyer O; Benveniste O;
Medicine (Baltimore); 2014 May; 93(3):150-157. PubMed ID: 24797170
[TBL] [Abstract][Full Text] [Related]
17. Immune-Mediated Necrotizing Myopathy.
Pinal-Fernandez I; Casal-Dominguez M; Mammen AL
Curr Rheumatol Rep; 2018 Mar; 20(4):21. PubMed ID: 29582188
[TBL] [Abstract][Full Text] [Related]
18. [Screening of autoantibodies associated with necrotizing myopathy among undiagnosed chronic myopathy].
Kuru S; Suzuki S; Ogata K; Kobayashi M; Ishida C; Watanabe C; Matsumura T
Rinsho Shinkeigaku; 2017 Oct; 57(10):562-566. PubMed ID: 28954975
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous involvement in anti-HMGCR positive necrotizing myopathy.
Williams B; Horn MP; Banz Y; Feldmeyer L; Villiger PM
J Autoimmun; 2021 Sep; 123():102691. PubMed ID: 34332436
[TBL] [Abstract][Full Text] [Related]
20. Anti-HMGCR myopathy: barriers to prompt recognition.
Barp A; Merve A; Shah S; Desikan M; Hanna MG; Bugiardini E
Pract Neurol; 2023 Jun; 23(3):239-242. PubMed ID: 36564213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
